Synovial sarcoma (SS) is a highly malignant tumor that accounts for 10% of all soft-tissue sarcomas. Primary SS arising from the lung is extremely rare, and the prognosis is poor. We report a case of pulmonary SS presenting with a mass lesion invading the right upper and middle lobes, extending to the mediastinum and the chest wall. After tru-cut biopsy, surgical resection was performed. The final diagnosis was SS (biphasic type) based on histological and immunohistochemical findings. There are no guidelines for optimal treatment due to the rarity of these tumors. Current treatment includes surgery and adjuvant chemotherapy and/or radiotherapy. 
CASE REPORT
Synovial sarcoma (SS) is a highly malignant tumor that occurs mainly in adolescents and young adults and is usually seen in the extremities [1] . However, primary synovial sarcoma arising from the lung is extremely rare, accounting for 0.3% to 1.3% [2] . It is closely associated with smoking [3] .
Besides clinical evaluation and imaging methods for definitive diagnosis, immunohistochemical examination is needed. We report a case of pulmonary SS with a history of heavy smoking.
A 69-year-old man was admitted to the hospital with Wilm's tumor-1, actin, caldesmon, CD34, S-100, pan-cytokeratin, and endomysial antibodies (EMA) (Fig. 4) . The epithelium of gland-like structures was positive for EMA and pan-cytokeratin (Fig. 4) . The epithelial groups at the periphery of the tumor were positive for thyroid transcription factor which results from the fusion of the SYT gene on chromosome 18 to either of two genes, SSX1 and SSX2 in the region xp11 [6] . Despite its high sensitivity, molecular testing is not essential for the diagnosis of SS. In our case, molecular testing was not performed due to the certain diagnosis of SS on the basis of clinical, histological, and immunohistochemical findings.
Sixty six percent of primary pulmonary SS are centrally located and present with obstructive pneumonia, hemoptysis, dyspnea, cough, and fever [7] . Peripheral tumors are rare. SS can also arise from the pleura. However, primary SS of the pleura is also very rare and there are a limited number of reported cases [8] . Our case presented with a centrally located tumor and a complaint of chest pain. The tumor was adjacent to the pleura, but there was no pleural involvement microscopically.
Surgical resection with tumor negative margins is the primary treatment. Prior to surgery, the primary focus of SS or metastasis should be excluded by imaging procedures. These tumors are highly aggressive, and the overall prognosis is poor [9] . There are no guidelines for optimal treatment due to the rarity of these tumors. Current treatment includes adjuvant chemotherapy and/or radiotherapy [6, 7] . Our patient underwent right bilobectomy and mediastinal lymph node dissection and then, received four cycles of adjuvant chemotherapy and radiotherapy postoperatively.
In conclusion, primary pulmonary SS is an extremely rare and aggressive tumor. Immunohistochemical staining and clinical imaging is necessary for definitive diagnosis. Surgical resection along with adjuvant chemo-radiotherapy is the currently accepted therapy.
